Leap Therapeutics, Inc.
General ticker "LPTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $36.4M (TTM average)
Leap Therapeutics, Inc. follows the US Stock Market performance with the rate: 1.1%.
Estimated limits based on current volatility of 19.2%: low 0.84$, high 1.25$
Factors to consider:
- Total employees count: 54 (+22.7%) as of 2023
- Top business risk factors: Operational and conduct risks, Funding requirements, Product development risks, Manufacturing risks, Third-party risks
- Current price 31.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.85$, 5.36$]
- 2025-12-31 to 2026-12-31 estimated range: [1.27$, 3.87$]
Financial Metrics affecting the LPTX estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -55.33 <= 0.33
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Shareholder equity ratio, % of 71.35 > 63.39
- Negative: negative Industry operating cash flow (median)
Short-term LPTX quotes
Long-term LPTX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $56.76MM | $87.04MM | $70.06MM |
| Operating Income | $-56.76MM | $-87.04MM | $-70.06MM |
| Non-Operating Income | $2.31MM | $5.63MM | $3.09MM |
| Interest Expense | $0.05MM | $0.00MM | $0.00MM |
| R&D Expense | $44.97MM | $73.23MM | $57.21MM |
| Income(Loss) | $-54.45MM | $-81.41MM | $-66.97MM |
| Taxes | $0.15MM | $0.00MM | $0.58MM |
| Profit(Loss)* | $-54.60MM | $-81.41MM | $-67.56MM |
| Stockholders Equity | $58.87MM | $60.14MM | $35.05MM |
| Inventory | $1.40MM | $0.00MM | $0.00MM |
| Assets | $70.35MM | $72.83MM | $49.12MM |
| Operating Cash Flow | $-49.04MM | $-43.75MM | $-60.30MM |
| Investing Cash Flow | $0.00MM | $48.97MM | $0.00MM |
| Financing Cash Flow | $-0.21MM | $-0.03MM | $37.18MM |
| Earnings Per Share** | $-4.82 | $-3.98 | $-1.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.